James Watson’s Personal Genome Published in Nature


By Kevin Davies

April 16, 2008 | Fifty-five years after James Watson co-authored the most famous paper in Nature magazine’s history -- the discovery of the DNA double helix with Francis Crick -- his genome sequence is also gracing the pages of the famous scientific journal.

Following months of extensive review and revision, Nature finally publishes the paper reporting the Watson’s personal genome, or “Project Jim” as it was known, this week. The sequencing itself was performed by 454 Life Sciences, part of Roche, led by its founder and past chairman, Jonathan Rothberg. The bioinformatics analysis was handled by scientists at the Baylor College of Medicine genome center, led by Director Richard Gibbs and bioinformatician David Wheeler.

Watson’s sequence becomes the second full human genome sequence to be published, following the publication of Craig Venter’s sequence last year. But whereas Venter’s genome took years of work using traditional Applied Biosystems sequencing instruments, costing a reputed $70 million, the Watson genome was sequenced in a couple of months early last year using the 454 GS FLX pyrosequencing instruments. 454 estimates the final cost to be between $1-2 million. “This is the first [human] genome sequenced by next-generation technologies,” the authors emphasize.

 Jonathan Rothberg, James Watson 
James Watson (left) receives a digital copy of his genome sequence from Jonathan Rothberg in May 2007.

 

Last May, Rothberg presented a digital copy of the raw sequence on a portable hard drive to Watson in a ceremony at Baylor College of Medicine. (Rothberg is no longer affiliated with 454/Roche.) Watson’s genome assembly – with the exception of one Alzheimer’s associated gene (APOE on chromosome 19) that was redacted at Watson’s behest -- has been publicly annotated and presented by Lincoln Stein at Cold Spring Harbor Laboratory.

The Nature paper details the highlights of Watson’s genome analysis. All told, more than 93 million DNA sequence traces, averaging about 250 bases in length, were assembled to produce the final sequence. Of those, more than 1 million did not correspond to the reference genome sequence, indicating there is much more genomic variation between individuals than previously thought. The 454 team also points out that its amplification procedure dispenses with bacteria, and thus leads to more even representation of the full genome.

The final tally of 24.5 billion bases provides more than seven-fold coverage of the genome. Wheeler and colleagues documented more than 3.3 million single nucleotide polymorphisms (SNPs), of which more than 10,000 alter the primary amino-acid sequence of proteins.

The paper contains a one-page box written by Baylor bioethicist Amy McGuire on the ethical considerations in handling and communicating this genetic and medical information with Dr. Watson.

LSWebcast logoEditor’s Note: Last year, Kevin Davies interviewed lead author David Wheeler on the sequencing of the Watson genome. See the full interview here.

Further Reading: Wheeler, D. et al. “The complete genome of an individual by massively parallel DNA sequencing.” Nature 452; April 17, 2008. doi:10.1038/nature06884

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

definiens briefingon-76Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



gq nxt gen seq

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



Life Science Webcasts & Podcasts

GenoLogicsgenologics 2 translational
Enabling Translational Research Informatics

Learn about the challenges facing life sciences research labs to manage their translational research data:

  • The trends for organizations to adopt informatics solutions for translational research.
  • The unique requirements with managing complex data and workflow.
  • What labs should consider when reviewing informatics solutions for translational research.
  • Which life sciences research organizations are successfully adopting an informatics solution.

Download Now



More Podcasts

Job Openings

Assistant Editor (Science Writer)~Cambridge Healthtech Institute (CHI), Needham, MA, 
Cambridge Healthtech Institute seeks an assistant editor (science writer) who is an ambitious, dependable journalist who can fulfill a range of writing and editorial duties for a series of eNewsletters covering various aspects of the biopharmaceutical industry in addition to CHI’s flagship publication, Bio-IT World magazine.  This is a superb opportunity to make important contributions to the growth and success of a multimedia science publishing group, while gaining invaluable experience in multiple facets of the publishing industry.   Interested candidates should submit a cover letter, including 3 writing samples (attached in Word or PDF format), salary history or requirements, and resume to kdavies@healthtech.com. 

Fred Hutchinson Cancer Research Center: IT Business Analyst III
The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Through our Tumor Research Initiative, we are finding new ways to detect tumors at an early stage.  We are presently seeking an experienced IT Business Analyst to assess technology needs for the Tumor Research Initiative, and to identify and design improvements to computer based systems.  For more information please visit www.fhcrc.org and search for Job# AD-21465

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.